Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AMRX

Amneal Pharmaceuticals Inc

May 29 • 04:00PM ET

13.17

+0.22 1.70 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Mid • NASD

Peers: TEVA VTRS BHC PRGO INDV ALKS LNTH KNSA HRMY OPK

| Held by: IJR VTI VB IWM VBR VXF XSMO SPSM IWO DFAS

Scroll to Statements

Index	RUT	P/E	35.31	EPS (ttm)	0.37	Insider Own	51.00%	Shs Outstand	319.00M	Perf Week	6.04%
Market Cap	4.20B	Forward P/E	11.40	EPS next Y	1.15	Insider Trans	-0.02%	Shs Float	156.32M	Perf Month	2.89%
Enterprise Value	6.78B	PEG	0.66	EPS next Q	0.23	Inst Own	47.40%	Short Float	5.10%	Perf Quarter	-4.63%
Income	122.12M	P/S	1.38	EPS this Y	18.72%	Inst Trans	3.64%	Short Ratio	4.39	Perf Half Y	5.87%
Sales	3.05B	P/B	-	EPS next Y	17.20%	ROA	3.54%	Short Interest	7.96M	Perf YTD	4.52%
Book/sh	-0.14	P/C	20.82	EPS next 5Y	17.22%	ROE	-	52W High	15.42 -14.59%	Perf Year	80.41%
Cash/sh	0.63	P/FCF	20.47	EPS past 3/5Y	- -18.36%	ROIC	4.64%	52W Low	7.07 86.28%	Perf 3Y	480.18%
Dividend Est.	-	EV/EBITDA	10.42	Sales past 3/5Y	10.92% 8.66%	Gross Margin	38.66%	Volatility	2.34% 3.04%	Perf 5Y	132.69%
Dividend TTM	-	EV/Sales	2.23	EPS Y/Y TTM	1018.25%	Oper. Margin	14.58%	ATR (14)	0.39	Perf 10Y	-60.72%
Dividend Ex-Date	-	Quick Ratio	1.59	Sales Y/Y TTM	7.62%	Profit Margin	4.01%	RSI (14)	59.10	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	2.47	EPS Q/Q	403.46%	SMA20	3.57%	Beta	1.30	Target Price	17.20
Payout	0.00%	Debt/Eq	-	Sales Q/Q	3.90%	SMA50	4.16%	Rel Volume	1.20	Prev Close	12.95
Employees	8500	LT Debt/Eq	-	Earnings	Apr 22 BMO	SMA200	9.63%	Avg Volume	1.82M	Price	13.17
IPO	Dec 19, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	59.67% 0.40%	Trades		Volume	2,187,129	Change	1.70%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)